Litigation Details for Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc. (D. Del. 2020)
✉ Email this page to a colleague
Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc. (D. Del. 2020)
| Docket | ⤷ Try a Trial | Date Filed | 2020-11-30 |
| Court | District Court, D. Delaware | Date Terminated | 2023-09-19 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | Plaintiff | Referred To | Jennifer L. Hall |
| Parties | HIKMA PHARMACEUTICALS PLC. | ||
| Patents | 10,568,861; 8,642,077; 9,700,537 | ||
| Attorneys | Jonathan E. Singer | ||
| Firms | Phillips, Goldman, McLaughlin & Hall, P.A. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc. (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-11-30 | 1 | Complaint | U.S. Patent Nos. 9,700,537 (“the ’537 patent”), 8,642,077 (the “’077 patent”), and 10,568,861 (the “… “’861 patent”) (collectively, the Asserted Patents”) under the Patent Laws of the United States, 35 …enforce its patents in federal court. 79. When the listed patent is a method-of-use patent, like … The Asserted Patents 37. On July 11, 2017, the United States Patent and Trademark Office… the ’537 patent is attached to this complaint as Exhibit C. 38. The ’537 patent is assigned | External link to document |
| 2022-02-15 | 103 | Answer to Counterclaim | U.S. Patent Nos. 9,700,537 (the “’537 Patent”) 8,642,077 (the “’077 Patent”), and/or 10,568,861 (the…’537 Patent are invalid for failure to meet one or more of the requirements for patentability of Title…’077 Patent are invalid for failure to meet one or more of the requirements for patentability of Title…’861 Patent are invalid for failure to meet one or more of the requirements for patentability of Title…1338(a), in that the counterclaims arise under the Patent Laws of the United States, 35 U.S.C. § 100 et | External link to document |
| 2022-03-31 | 108 | Motion - Miscellaneous | claims against Hikma only as to U.S. Patent Nos. 9,700,537 and 10,568,861. Case 1:20-cv-01630-RGA-JLH Document…production or 1 Amarin no longer asserts U.S. Patent No. 8,642,077 against Hikma and seeks to appeal… 19 September 2023 1:20-cv-01630 830 Patent Plaintiff District Court, D. Delaware | External link to document |
| 2022-06-10 | 123 | Opening Brief in Support | against Hikma only as to U.S. Patent Nos. 9,700,537 and 10,568,861.” Id. …goals of “prompt resolution” and “patent certainty” in pharmaceutical patent disputes, which benefit litigants…Plaintiffs’ patents by encouraging the use of Hikma’s generic for the [allegedly patented] indication… of Plaintiffs’ patents for the [cardiovascular] indication” that Amarin’s patents allegedly cover…Plaintiffs’ patents by encouraging the use of Hikma’s generic for the [allegedly patented] indication | External link to document |
| 2021-01-25 | 17 | Amended Complaint | U.S. Patent Nos. 9,700,537 (“the ’537 patent”), 8,642,077 (the “’077 patent”), and 10,568,861 (the …composition and methods of using same), and 10,568,861 (Methods of reducing the risk of a cardiovascular…the “’861 patent”) (collectively, the “Asserted Patents”) under the Patent Laws of the United States, …enforce its patents in federal court. 95. When the listed patent is a method-of-use patent, like… The Asserted Patents 41. On July 11, 2017, the United States Patent and Trademark Office | External link to document |
| 2021-01-27 | 20 | Opening Brief in Support | U.S. Patent Nos. 9,700,537 (“the ’537 patent”), 8,642,077 (“the ’077 patent”), and 10,568,861 (“the…related patents. In fact, Amarin never asserted any of the patents-in-suit in its first patent infringement…the ’861 patent”) (collectively, “patents-in-suit”). Hikma moved to dismiss. D.I. 11. Amarin’s First … 994. Patents-in-suit. Amarin asserts induced infringement for three patents covering the CV…......................................10 U.S. Patent Nos. 9,700,537 ................................ | External link to document |
| 2020-11-30 | 3 | Patent/Trademark Report to Commissioner | ;US 8,642,077 ;US 10,568,861. (apk) (Entered: 12/01/2020) 30 November 2020 PACER Document … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,700,537 ;… 19 September 2023 1:20-cv-01630 830 Patent Plaintiff District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
